Investigational drugs for the treatment of olfactory dysfunction.

Arianna Di Stadio Cinzia SeveriniAndrea ColizzaMarco De VincentiisIgnazio La Mantia

Published in: Expert opinion on investigational drugs (2022)

Because COVID-19 causes olfactory loss and several treatments (topical and systemic) have been tested in this disease, we have decided to use this model of acquired olfactory loss to discuss the different therapeutical option. The authors believe these treatments might be an option also for treating olfactory disease related to neurodegeneration.

Keyphrases

coronavirus disease
sars cov
oxidative stress
randomized controlled trial
wound healing
study protocol